Steven Cohen’s ArriVent BioPharma AVBP Stock Holding History
Bought
Maintained
Sold
Other funds holding AVBP
IAM
Steven Cohen's AVBP Position: Q3 2026 in Review
Steven Cohen reduced its ArriVent BioPharma (AVBP) stake by 13% in Q3 2026, selling an estimated $2.25M and leaving 493,205 shares worth $14.9M. The position accounts for 0.02% of the portfolio, ranked #1091.
Steven Cohen first reported a position in AVBP in Q1 2024 and has held it in 5 quarters since. The position peaked at $19.7M in Q2 2026. 151 funds tracked by Wall St. Rank hold AVBP as of Q3 2026.
- Steven Cohen held 493,205 shares of ArriVent BioPharma worth $14.9M as of Q3 2026.
- Steven Cohen sold 73,591 ArriVent BioPharma shares in Q3 2026, an estimated $2.25M.
- ArriVent BioPharma made up 0.02% of Steven Cohen's portfolio in Q3 2026, its #1091 holding.
- Steven Cohen first reported a position in ArriVent BioPharma in Q1 2024 and has held it in 5 quarters since.
- Steven Cohen's ArriVent BioPharma position peaked at $19.7M in Q2 2026.
- 151 funds tracked by Wall St. Rank held ArriVent BioPharma as of Q3 2026.
Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.